PECAM1 and cancer: With the aim of evaluating the effects of cancer cells upon the hASCs' capability of promoting angiogenesis, CD31, VEGF, PDGFA, PDGFRα, PDGFRβ gene expression was analysed at 7, 14 and 21 days (Figure 4).